1. Home
  2. COKE vs HALO Comparison

COKE vs HALO Comparison

Compare COKE & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coca-Cola Consolidated Inc.

COKE

Coca-Cola Consolidated Inc.

N/A

Current Price

$207.60

Market Cap

13.5B

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$103.60

Market Cap

14.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COKE
HALO
Founded
1902
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
14.8B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
COKE
HALO
Price
$207.60
$103.60
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $108.89
AVG Volume (30 Days)
492.0K
★ 2.0M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 0.47%
N/A
EPS Growth
★ 156.81
N/A
EPS
1.21
★ 5.12
Revenue
★ $7,228,055,000.00
$151,862,000.00
Revenue This Year
N/A
$34.73
Revenue Next Year
N/A
$11.71
P/E Ratio
$168.74
★ $41.91
Revenue Growth
★ 4.76
N/A
52 Week Low
$136.97
$61.23
52 Week High
$218.73
$134.00

Technical Indicators

Market Signals
Indicator
COKE
HALO
Relative Strength Index (RSI) 52.63 28.68
Support Level $179.77 $64.08
Resistance Level $214.39 $111.15
Average True Range (ATR) 8.77 4.39
MACD -0.58 -2.09
Stochastic Oscillator 30.38 0.42

Price Performance

Historical Comparison
COKE
HALO

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: